UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells

Oncogene, 2013-09, Vol.32 (36), p.4284-4293

2013

Volltextzugriff (PDF)

Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients

Annals of oncology, 2011-06, Vol.22 (6), p.1346-1352

2011

Volltextzugriff (PDF)

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

Breast cancer research and treatment, 2012-06, Vol.133 (3), p.937-947

2012

Volltextzugriff (PDF)

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

British journal of cancer, 2014-08, Vol.111 (5), p.1004-1013

2014

Volltextzugriff (PDF)

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

Breast cancer research and treatment, 2011-01, Vol.125 (2), p.387-394

2011

Volltextzugriff (PDF)

CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

Breast cancer research and treatment, 2013-07, Vol.140 (2), p.363-373

2013

Volltextzugriff (PDF)

CYP2C192 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment

Breast cancer research and treatment, 2013-06, Vol.139 (3), p.649-655

2013

Volltextzugriff (PDF)

The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer

British journal of cancer, 2010-09, Vol.103 (6), p.765-771

2010

Volltextzugriff (PDF)

Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)

British journal of pharmacology, 2010-02, Vol.159 (4), p.898-908

2010

Volltextzugriff (PDF)

Alterations in the p53 pathway and prognosis in advanced ovarian cancer: A multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)

European journal of cancer (1990), 2006-10, Vol.42 (15), p.2539-2548

2006

Volltextzugriff (PDF)

Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset

The journal of clinical endocrinology and metabolism, 2003-04, Vol.88 (4), p.1653-1657

2003

Volltextzugriff (PDF)

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2

British journal of cancer, 2001-11, Vol.85 (9), p.1359-1367

2001

Volltextzugriff (PDF)

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer

British journal of cancer, 1998-04, Vol.77 (7), p.1130-1136

1998

Volltextzugriff (PDF)

Additional value of the 70-gene signature and levels of ER and PR for the prediction of outcome in tamoxifen-treated ER-positive breast cancer

Breast (Edinburgh), 2012-12, Vol.21 (6), p.769-778

2012

Volltextzugriff (PDF)

p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer

Journal of clinical oncology, 1998-01, Vol.16 (1), p.121-127

1998

Volltextzugriff (PDF)

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer

Cancer research (Chicago, Ill.), 2000-04, Vol.60 (8), p.2155-2162

2000

Volltextzugriff (PDF)

Allelotype of 28 human breast cancer cell lines and xenografts

British journal of cancer, 2003-12, Vol.89 (12), p.2289-2292

2003

Volltextzugriff (PDF)

Serum proteomic patterns for ovarian cancer monitoring

International journal of gynecological cancer, 2008-09, Vol.18 (5), p.985-995

2008

Volltextzugriff (PDF)

Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features

British journal of cancer, 2001-08, Vol.85 (4), p.538-545

2001

Volltextzugriff (PDF)

Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours

British journal of cancer, 1996-10, Vol.74 (7), p.1069-1073

1996

Volltextzugriff (PDF)

Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence

British journal of cancer, 1995-11, Vol.72 (5), p.1330-1336

1995

Volltextzugriff (PDF)

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer

Cancer research (Chicago, Ill.), 1992-03, Vol.52 (5), p.1107-1113

1992

Volltextzugriff (PDF)

The VEGF pathway and the AKT mTOR p70S6K1 signalling pathway in human epithelial ovarian cancer

British journal of cancer, 2009-03, Vol.100 (6), p.971-978

2009

Volltextzugriff (PDF)

Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer

Breast cancer research and treatment, 1998-03, Vol.48 (1), p.87-92

1998

Volltextzugriff (PDF)

Prognostic Significance of Germline BRCA2 Mutations in Hereditary Breast Cancer Patients

Journal of clinical oncology, 2000-11, Vol.18 (suppl 1), p.119s-124s

2000

Volltextzugriff (PDF)

1 – 25 von 590

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(537)
Mit Volltextzugriff
(504)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(366)
Life Sciences & Biomedicine
(293)
Humans
(239)
Female
(168)
Biological And Medical Sciences
(167)
Medical Sciences
(124)
Animals
(121)
Male
(97)
Oncology
(94)
Middle Aged
(83)
Adult
(81)
Aged
(79)
Tumors
(71)
Mice
(52)
Gynecology. Andrology. Obstetrics
(47)
Cell Biology
(46)
Fundamental And Applied Biological Sciences. Psychology
(46)
Breast Neoplasms - Genetics
(45)
Prognosis
(42)
Aged, 80 And Over
(41)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(330)
EZB Electronic Journals Library
(293)
Ingenta
(232)
Journals@Ovid
(205)
Single Journals
(147)
Elsevier ScienceDirect Journals Complete
(137)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(95)
Wiley-Blackwell Journals
(88)
Wiley Online Library Full Collection 2018
(68)
IngentaConnect Journals
(61)
Nature Research
(43)
2022 ECC(Springer)
(43)
JSTOR
(36)
Nexis Uni
(28)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(26)
APS_美国物理学会期刊
(24)
Oxford Journals
(22)
Psychology & Behavioral Sciences Collection
(19)
Oxford Journals 2020 Medicine
(17)
PROLA
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

British Journal Of Cancer
(14)
Nature
(14)
Physical Review. D
(14)
Cancer Research
(13)
Oceanography
(12)
Breast Cancer Research And Treatment
(11)
International Journal Of Cancer
(11)
Annals Of Oncology
(10)
Physical Review D
(10)
Cell
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells

Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

CYP2C192 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment

The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer

Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)

Alterations in the p53 pathway and prognosis in advanced ovarian cancer: A multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)

Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer

Additional value of the 70-gene signature and levels of ER and PR for the prediction of outcome in tamoxifen-treated ER-positive breast cancer

p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer

Allelotype of 28 human breast cancer cell lines and xenografts

Serum proteomic patterns for ovarian cancer monitoring

Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features

Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours

Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer

The VEGF pathway and the AKT mTOR p70S6K1 signalling pathway in human epithelial ovarian cancer

Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer

Prognostic Significance of Germline BRCA2 Mutations in Hereditary Breast Cancer Patients

Suchergebnisse filtern